Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2012 | 08-2012 | 09-2011 | 09-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 7,860 | N/A | 990 | N/A |
| Receivables | 178 | N/A | 10 | N/A |
| Other current assets | 97 | 0 | 40 | 0 |
| TOTAL | $8,135 | $N/A | $1,040 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 246 | N/A | 330 | N/A |
| Other Non-Current Assets | 150 | 0 | 0 | 0 |
| TOTAL | $396 | $N/A | $330 | $N/A |
| Total Assets | $8,513 | $N/A | $1,540 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 430 | 0 | 0 | 0 |
| Other current liabilities | 120 | N/A | N/A | N/A |
| TOTAL | $3,874 | $N/A | $560 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 130 | 0 | 0 | 0 |
| TOTAL | $130 | $N/A | $N/A | $N/A |
| Total Liabilities | $10,709 | $N/A | $690 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 8,010 | N/A | N/A | N/A |
| Retained earnings | -25,181 | N/A | -10,310 | N/A |
| Other shareholders' equity | 14,975 | 0 | 11,160 | 0 |
| TOTAL | $-2,196 | $N/A | $850 | $N/A |
| Total Liabilities And Equity | $8,513 | $0 | $1,540 | $0 |